Breath Biopsy Testing Market Report 2026

Breath Biopsy Testing Market Overview

• Breath Biopsy Testing market size has reached to $3.43 billion in 2025 • Expected to grow to $4.9 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Impact Of Increased Respiratory Conditions On Breath Biopsy Testing Market Growth • Market Trend: Innovative Advances In Breath Biopsy Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Breath Biopsy Testing Market?

Breath biopsy testing is a non-invasive diagnostic method that analyzes the chemical compounds in a person's breath to detect and diagnose diseases. This testing is based on the principle that certain diseases, metabolic conditions, and physiological states produce unique chemical markers or volatile organic compounds (VOCs) that can be detected in the exhaled breath. The main types of breath biopsy testing include volatile organic compound analyzers, breath biopsy kits, breath samplers, and others. Volatile organic compound (VOC) analyzers are instruments designed to detect and measure the concentration of volatile organic compounds in the air. It uses various technologies such as fuel cell technology, semiconductor sensors, infrared (IR) spectroscopy, and others, and it is applied in hospitals, clinics, diagnostic laboratories, and others.

What Is The Breath Biopsy Testing Market Growth Forecast?

The breath biopsy testing market size is expected to see strong growth in the next few years. It will grow to $4.9 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing adoption of breath-based diagnostics in routine screening, rising investments in ai-enabled diagnostic platforms, expansion of personalized medicine applications, growing use of portable diagnostic devices, increasing regulatory support for non-invasive testing. Major trends in the forecast period include increasing adoption of non-invasive diagnostic techniques, rising use of voc-based disease detection, growing integration of AI-driven breath analysis, expansion of portable breath sampling devices, enhanced focus on early disease screening.

Global Breath Biopsy Testing Market Segmentation

1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types 2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies 3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications Subsegments: 1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices 2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits 3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices 4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

What Is The Driver Of The Breath Biopsy Testing Market?

The rising prevalence of respiratory diseases is expected to propel the growth of the breath biopsy testing market going forward. Respiratory diseases refer to medical conditions that impact on the lungs and airways, hindering a person’s ability to breathe efficiently. The prevalence of respiratory diseases is due to increasing environmental pollution, higher rates of smoking, and the growing prevalence of chronic conditions such as asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing is required for respiratory diseases to offer a non-invasive, rapid, and potentially more accurate method for detecting biomarkers associated with these conditions, improving early diagnosis and management. For instance, in May 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, chronic obstructive pulmonary disease (COPD) ranked as the fifth leading cause of death in the United States in 2023, accounting for 141,733 deaths. During the same year, the age-adjusted prevalence of diagnosed COPD among adults reached 3.8%. Therefore, the rising prevalence of respiratory diseases will drive the growth of the breath biopsy testing industry.

Key Players In The Global Breath Biopsy Testing Market

Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

Global Breath Biopsy Testing Market Trends and Insights

Major companies operating in the breath biopsy testing market are focused on developing innovative products, such as breath analyzers, to detect asthma. Breath analyzers are diagnostic devices that detect and measure specific compounds in a person’s breath to identify medical conditions or assess health status. For instance, in May 2023, GenWorks, an India-based healthcare solutions provider, launched the FenomPro breath analyzer. The FenomPro breath analyzer offers a unique feature with its rapid FeNO testing capability, delivering results in just 28 seconds. Designed for ease of use in clinical settings, it provides accurate assessments for diagnosing, screening, and monitoring asthma. The device is equipped with a rechargeable battery for portability, features a user-friendly interface, and efficiently determines whether patients need treatment or inhaler prescriptions.

What Are Latest Mergers And Acquisitions In The Breath Biopsy Testing Market?

In November 2023, Syantra Inc., a Canada-based liquid biopsy platform and innovation company, partnered with Limmi to accelerate the AI-powered RNA-based early cancer detection liquid biopsy program. The collaboration with Limmi brings a scalable AI-powered liquid biopsy platform that generates novel insights from clinical data, strengthening Syantra's ability to detect multiple cancers at early stages. Limmi is a US-based technology company.

Regional Outlook

North America was the largest region in the breath biopsy testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Breath Biopsy Testing Market?

The breath biopsy testing market consists of revenues earned by entities by providing services such as metabolic disorder screening, gastrointestinal health assessment, predictive screening and non-invasive testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The breath biopsy testing market also includes sales of breath collection devices, diagnostic software, portable breath testers and wearable breath sensors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Breath Biopsy Testing Market Report 2026?

The breath biopsy testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the breath biopsy testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.